Abstract
Objective: Patients with unilateral vocal fold paralysis commonly report dysphonia and dysphagia. Dyspnea also occurs, with studies on treatment-related change producing mixed results. Studies including patient-reported outcomes have focused on single-question global scales. The Dyspnea Index (DI) includes 10 questions, is specific to upper airway–related dyspnea, and may better capture these patients’ symptoms. We evaluated change in DI after treatment. Study Design: Retrospective review. Setting: Academic medical center. Methods: Forty-three patients with unilateral vocal fold paralysis underwent injection augmentation (n = 25) or framework surgery (n = 18). DI was recorded preprocedure, 2 to 4 weeks afterward, and at approximately 3 months afterward in 19 patients. Voice Handicap Index–10, Glottal Function Index, Cough Severity Index, and Eating Assessment Tool–10 were also recorded. Change in parameters and correlations were assessed. Obesity, cardiac disease, pulmonary disease, and procedure (injection vs framework surgery) were evaluated for effect on DI. Results: Twenty-four patients had an abnormal baseline DI (>10). DI decreased from 14.9 ± 13.8 to 6.5 ± 9.3 after treatment (P
Author supplied keywords
Cite
CITATION STYLE
Hoffman, M. R., Vandiver, B., Derise, N., Hapner, E. R., Leverson, G., & Simpson, C. B. (2022). Effect of Medialization on Dyspnea Index in Unilateral Vocal Fold Paralysis. Otolaryngology - Head and Neck Surgery (United States), 167(2), 327–333. https://doi.org/10.1177/01945998211056515
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.